Invictus Oncology Pvt. Ltd.

Calculating rank

USPTO Granted Patents = 4

% Expired Patents = 75.0

Forward Citations = 7

Loading Chart...

14 inventors (with patents filed for the assignee):

Shiladitya Sengupta (3 out of 21 patents)

Monideepa Roy (3 out of 7 patents)

Anubhab Mukherjee (2 out of 2 patents)

4. Arindam Sarkar (1 out of 4 patents)

5. Ashish Kulkarni (1 out of 6 patents)

6. Goutam Biswas (1 out of 2 patents)

7. Hemant Suryavanshi (1 out of 1 patent)

8. Aniruddha Sengupta (1 out of 3 patents)

9. Seikh Samad Hossain (1 out of 3 patents)

10. Samad Hossain (1 out of 1 patent)

11. Sanghamitra Mylavarapu (1 out of 1 patent)

12. Swadhin Kumar Mandal (1 out of 1 patent)

13. Sazid Hussain (1 out of 1 patent)

14. Dipankar Pramanik (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 10736968 - Cellular signalling inhibitors, their formulations and methods thereof (2020-08-11),

2. 10426753 - Supramolecular combinatorial therapeutics (2019-10-01),

3. 10017531 - Lipid-based platinum-N-heterocyclic carbene compounds and nanoparticles (2018-07-10),

4. 9884123 - Ligand-targeted molecules and methods thereof (2018-02-06),

Company Overview

Invictus Oncology Pvt. Ltd. is a cutting-edge biotechnology company focused on developing novel cancer therapies. Our team of experts is dedicated to revolutionizing the way cancer is treated by leveraging advanced technologies and innovative research. With a commitment to improving patient outcomes and quality of life, Invictus Oncology is leading the way in the fight against cancer.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#5 in Delhi

#376 in India

Delhi, India